Gd2.zip

GD2 is a , a type of glycosphingolipid found on the surface of cells. It is primarily recognized as a tumor-associated antigen (TAA) because it is highly overexpressed in various cancers—specifically those of neuroectodermal origin—while remaining largely absent in most healthy adult tissues. Biological Structure and Synthesis

T-cells are engineered to recognize and kill GD2-expressing cells. This has shown significant promise in clinical trials for pediatric brain tumors.

GD2 is an amphiphilic molecule consisting of a hydrophobic ceramide tail (which anchors it to the cell membrane) and a hydrophilic oligosaccharide head containing two sialic acid residues . gd2.zip

Vaccines aim to stimulate the patient's own immune system to produce anti-GD2 antibodies, while small DNA/RNA molecules (aptamers) are being researched to deliver drugs directly to GD2-positive cells. Diagnostic Significance

In healthy adults, GD2 expression is restricted to the brain , peripheral nerves, and skin melanocytes. Role in Cancer GD2 is a , a type of glycosphingolipid

Found on cancer stem cells in these aggressive subtypes.

It is synthesized in the Golgi apparatus from precursors like GM3 and GD3. Key enzymes in this pathway include ST8SIA1 (GD3 synthase) and B4GALNT1 (GD2 synthase). This has shown significant promise in clinical trials

GD2 is often a marker for cancer stem cells , which are responsible for tumor initiation, drug resistance, and metastasis. Therapeutic Approaches